Evidence map›Paper›PMID 34620254›Full record

ArticleActa neuropathologica communications2021

Low-grade peripheral inflammation affects brain pathology in the App

Junhua Xie, Nina Gorlé, Charysse Vandendriessche, Griet Van Imschoot, Elien Van Wonterghem, Caroline Van Cauwenberghe, Eef Parthoens, Evelien Van Hamme, Saskia Lippens, Lien Van Hoecke and 1 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Gut-derived bacterial vesicles carrying lipopolysaccharide promote microglia-mediated synaptic pruning.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  12. Review
  13. Neuroinflammation in Alzheimer disease.Nature reviews. Immunology · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Junhua XieVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Nina GorléVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Charysse VandendriesscheVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Griet Van ImschootVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Elien Van WonterghemVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Caroline Van CauwenbergheVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Eef ParthoensVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Evelien Van HammeVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Saskia LippensVIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Lien Van Hoecke *VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium.
Roosmarijn E Vandenbroucke *VIB-UGent Center for Inflammation Research, Technologiepark-Zwijnaarde 71, 9052, Ghent, Belgium. Roosmarijn.Vandenbroucke@irc.VIB-UGent.be.ORCID 0000-0002-8327-620X
Ghent University · BEVIB-UGent Center for Inflammation Research · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by the accumulation of amyloid β (Aβ) and neurofibrillary tangles. The last decade, it became increasingly clear that neuroinflammation plays a key role in both the initiation and progression of AD. Moreover, also the presence of peripheral inflammation has been extensively documented. However, it is still ambiguous whether this observed inflammation is cause or consequence of AD pathogenesis. Recently, this has been studied using amyloid precursor protein (APP) overexpression mouse models of AD. However, the findings might be confounded by APP-overexpression artifacts. Here, we investigated the effect of low-grade peripheral inflammation in the APP knock-in (App

Indexed as

Alzheimer DiseaseAmyloid beta-Protein PrecursorAnimalsBrainDisease Models, AnimalFemaleInflammationMaleMiceAmyloid beta-Protein PrecursorAlzheimer's diseaseBlood-CSF barrierBrain barriersChoroid plexusLow-grade peripheral inflammation

Identifiers

PMID34620254
PMCPMC8499584
OpenAlexW3201799820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.